TORONTO, Jan. 25, 2012 /CNW/ - Biosign Technologies Inc. (TSXV: BIO) ("Biosign") and EasyMed Services, Inc. (CNSX: EZM) (OTCBB: EMYSF) ("EasyMed") are pleased to announce they have executed agreements that allow the
resale and distribution of each other's respective products as well as
a Development and License Agreement for the creation of a joint product
Under the terms of the Agreements:
Biosign will have access to resell and distribute EasyMed products
within North America;
EasyMed will have access to resell and distribute Biosign products
Biosign and EasyMed shall jointly develop new healthcare products and
will share the revenue and intellectual property equally;
EasyMed shall become a mobile technology provider for Biosign's future
release of Healthanywhere™; and
Biosign shall promote the "Powered by EasyMed" brand.
As previously reported (see news December 5th, 2011), the companies intend to interface UFIT® devices into Easy
SmartCare and will make the offering available within their respective
territories. The combined solution provides benefits for payers,
providers, and patients through improved patient preparation for
medical visits, decreased absenteeism, better information for both the
patient and the caregiver, improved communication of medical results to
the patient, and enhanced outpatient management.
"We were looking for ways to increase patient access to our system and
we have found a great mobility partner in EasyMed" stated Dr. Scott
Jenkins, CEO of Biosign, adding "Together our companies are striving to
provide the solutions that enable people to better manage their health"
Andrew Ritchie, CEO of EasyMed commented, "The partnership between
Biosign and EasyMed will allow both companies to strengthen our product
offering and take advantage of our strong sales contacts in each of our
markets. We also believe that by developing a new product range that
takes advantage of both companies existing products and technology,
that we will meet a new growing demand by customers to be connected to
their healthcare professionals by mobile or internet technology. We are
very pleased we were able to conclude the agreements and can now start
the process of building a new solution for healthcare"
About EasyMed Services, Inc.
EasyMed Services, Inc. (CNSX: EZM) (OTCBB: EMYSF) provides technology
solutions for healthcare organizations to enable the delivery of
healthcare services on mobile devices while saving costs and improving
operational efficiency. The technology platform implements the latest
industry standards, is readily integrated into existing hospital
environments, and complies with HIPAA and multi-national regulations.
For more information on EasyMed, please visit: www.EasyMedmobile.com.
About Biosign Technologies Inc.
Biosign Technologies Inc. (TSXV: BIO) provides biomedical systems. Key
applications include intelligent systems for non-invasive monitoring of
common health risks associated with blood pressure, lifestyle, and
medication. The core technology combines measurement, analysis, and
rapid knowledge formation to support health monitoring across global
markets. The UFIT® medical device technology powers quality data
collection and analytics for clinical diagnostics, self-care, wellness,
disease state evaluation & management, and remote patient monitoring.
For more information on Biosign, please visit www.biosign.com.
This release contains forward-looking statements. Forward-looking
statements, without limitation, may contain the words believes,
expects, anticipates, estimates, intends, plans, or similar
expressions. Forward-looking statements are not guarantees of future
performance. They involve risks, uncertainties and assumptions and
Biosign's actual results could differ materially from those
anticipated. Forward looking statements are based on the opinions and
estimates of management at the date the statements are made, and are
subject to a variety of risks and uncertainties and other factors that
could cause actual events or results to differ materially from those
projected in the forward-looking statements. In the context of any
forward-looking information please refer to risk factors detailed in,
as well as other information contained in, Biosign's filings with
Canadian securities regulators (www.sedar.com).
Neither TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
SOURCE Biosign Technologies Inc.
For further information:
| Scott Jenkins, CEO |
Biosign Technologies Inc.
Phone: (416) 218-9800 ext. 234
| || Jared W. Scharf, CFO |
EasyMed Services, Inc.
(416) 662 3971
| || Biosign Investor Relations |
Bay Street Connect